Indeed, our MAGEA DNA vaccine successfully elicits effective T cell activities against each antigen and effectively eliminates GemR tumor cells expressing high levels of MAGEA2, MAGEA3, and MAGEA10 in two distinct mouse models of pancreatic cancer. Here, MAGEA10 is linked to neoplasm.